Atlas Trials

Patients Who Have Received Allo-HSCT

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Patients Who Have Received Allo-HSCT

RecordFirmDate
Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03343600)National Taiwan University Hospital2017-11-09
Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01252017)National Taiwan University Hospital2010-11-01

Track Patients Who Have Received Allo-HSCT automatically

Every clearance here is in the API, with alerts when new ones post.